NAXWAB Priority claimed from 18/03/2022; Application No. : 97319633 ;United States of America
Goods or services claimed
Pharmaceutical preparations for the rapid treatment of opioid toxicity and overdosage.
Similar marks in class 5, same issue
- TOTRUBY Priority claimed from 11/03/2022; Application No. : 97307729 ;United States of America similar · Principia Biopharma Inc.
- BRYZVAXDEN Priority claimed from 09/03/2022; Application No. : 97302992 ;United States of America sounds-alike · Johnson & Johnson
- ISVACDEN Priority claimed from 09/03/2022; Application No. : 97302988 ;United States of America sounds-alike · Johnson & Johnson
- GOLTRUBY Priority claimed from 15/02/2022; Application No. : 97267850 ;United States of America similar · Principia Biopharma Inc.
- GEVVUE Priority claimed from 17/06/2022; Application No. : 97/463158 ;United States of America similar · Johnson & Johnson
- EYVEOD Priority claimed from 17/06/2022; Application No. : 97/463121 ;United States of America similar · Johnson & Johnson
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for NAXWAB Priority claimed from 18/03/2022; Application No. : 97319633 ;United States of America
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.